BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18855579)

  • 21. Flow Cytometric Analysis of Nucleoside Transporters Activity in Chemoresistant Prostate Cancer Model.
    Drápela S; Fedr R; Khirsariya P; Paruch K; Svoboda M; Souček K
    Klin Onkol; 2018; 31(Supplementum1):140-144. PubMed ID: 29808688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells.
    Srivastava JK; Gupta S
    Biochem Biophys Res Commun; 2006 Jul; 346(2):447-53. PubMed ID: 16762318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A key role for caspase-2 and caspase-3 in the apoptosis induced by 2-chloro-2'-deoxy-adenosine (cladribine) and 2-chloro-adenosine in human astrocytoma cells.
    Ceruti S; Beltrami E; Matarrese P; Mazzola A; Cattabeni F; Malorni W; Abbracchio MP
    Mol Pharmacol; 2003 Jun; 63(6):1437-47. PubMed ID: 12761355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
    Li L; Zhu Z; Joshi B; Porter AT; Tang DG
    Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
    Lu Z; Zhou R; Kong Y; Wang J; Xia W; Guo J; Liu J; Sun H; Liu K; Yang J; Mi M; Xu H
    Curr Cancer Drug Targets; 2016; 16(5):455-65. PubMed ID: 26638886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.
    Luo Y; Ling Y; Guo W; Pang J; Liu W; Fang Y; Wen X; Wei K; Gao X
    J Control Release; 2010 Oct; 147(2):278-88. PubMed ID: 20655966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
    Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
    Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3.
    Aghaei M; Karami-Tehrani F; Panjehpour M; Salami S; Fallahian F
    Prostate; 2012 Mar; 72(4):361-75. PubMed ID: 21656837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Jungermannenone A and B induce ROS- and cell cycle-dependent apoptosis in prostate cancer cells in vitro.
    Guo YX; Lin ZM; Wang MJ; Dong YW; Niu HM; Young CY; Lou HX; Yuan HQ
    Acta Pharmacol Sin; 2016 Jun; 37(6):814-24. PubMed ID: 27133304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling.
    Koshiba M; Kosaka H; Nakazawa T; Hayashi N; Saura R; Kitamura N; Kumagai S
    Br J Pharmacol; 2002 Mar; 135(6):1477-86. PubMed ID: 11906961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species.
    Chen HM; Chang FR; Hsieh YC; Cheng YJ; Hsieh KC; Tsai LM; Lin AS; Wu YC; Yuan SS
    Free Radic Biol Med; 2011 May; 50(9):1151-62. PubMed ID: 21256211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anethole Inhibits the Proliferation of Human Prostate Cancer Cells via Induction of Cell Cycle Arrest and Apoptosis.
    Elkady AI
    Anticancer Agents Med Chem; 2018; 18(2):216-236. PubMed ID: 28745237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
    Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
    Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
    Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antitumor activities of 8-chloroadenosine in vivo and in vitro].
    Fang J; Shi Y; Zhang L
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):5-8. PubMed ID: 7656789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
    Henry JY; Lu L; Adams M; Meyer B; Bartlett JB; Dalgleish AG; Galustian C
    Prostate; 2012 Jun; 72(8):856-67. PubMed ID: 21968939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity.
    Teng Y; Cai Y; Pi W; Gao L; Shay C
    J Hematol Oncol; 2017 Jun; 10(1):118. PubMed ID: 28606127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells.
    Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Rothen-Rutishauser B; Guenthert M; Schwendener RA
    J Cancer Res Clin Oncol; 2000 May; 126(5):247-56. PubMed ID: 10815759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na
    Silva IT; Munkert J; Nolte E; Schneider NFZ; Rocha SC; Ramos ACP; Kreis W; Braga FC; de Pádua RM; Taranto AG; Cortes V; Barbosa LA; Wach S; Taubert H; Simões CMO
    Biomed Pharmacother; 2018 Nov; 107():464-474. PubMed ID: 30107342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
    Morales P; Vara D; Goméz-Cañas M; Zúñiga MC; Olea-Azar C; Goya P; Fernández-Ruiz J; Díaz-Laviada I; Jagerovic N
    Eur J Med Chem; 2013; 70():111-9. PubMed ID: 24141201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.